Specialist in medical cannabis
The Four 20 Pharma GmbH gives on this page a 360 ° view of the company and the thematic focus on medicinal cannabis.
Simply select an area of interest from the following navigation, click and go directly to the desired area on this page. Or scroll down and scan the entire range of topics chronologically. 5 minutes reading time. Doctors and pharmacies can be reached directly to our specialist area one click.
As an importer and wholesaler of medical cannabis and medical devices, we are GDP-certified and GMP-certified. We also have this quality claim on our suppliers and partners.
Four 20 Pharma GmbH, headquartered in Paderborn (Germany), holds a wholesale pharmaceutical surge in medicine in accordance with Section 52a AMG and a narcotics permit in accordance with Section 3 BtMG.
In addition, we have all the necessary import licenses for the import of medical cannabis into Germany as well as a permit in accordance with Section 7 AMG and 1 AMRadV for the movement of medicinal products that have been treated with ionizing radiation in order to reduce the number of germs.
We are a reliable partner for physicians, pharmacies, medical institutions and patients in the field of medical cannabis. We focus on quality, patient welfare and service.
Selection of partners according to the highest pharmaceutical quality standards.
We promote the diversity of medicines and improve patient health care.
Doctors and pharmacies receive assistance with questions about products and prescriptions.
With our compact overview of relevant events on the topic of medical cannabis, we would like to invite you to a personal conversation on site. Please contact us.
29 – 31 July 2020
Exhibition booth: 65
Europe’s largest cannabis B2B industry meeting point.
07 – 10 October 2020
Exhibition booth: follows
Europe’s largest trade fair around the pharmacy market.
The focus of our day-to-day activities is the best possible medical care for patients. With our wide range of medicinal cannabis, we help to provide optimal treatment for patients in need.
Our aim is to consistently comply with the highest pharmaceutical quality standards. That’s why we make sure that our suppliers and partners have GDP and GMP certification without exception.
Due to our philosophy, patients, doctors, pharmacies and medical institutions can rely on a constant quality of our medical cannabis products.
We are a specialist in the field of medicinal cannabis and offer high-quality products from the dried flower of the cannabis plant.
Since cannabis is listed in Appendix III of the Narcotics Act, we may only provide information on products to medical professionals.
Four 20 Pharma GmbH stands for the highest quality and meets the guidelines of GMP and GDP certification. In this way, we ensure that our pharmaceutical products meet established quality standards.
- Consistent product quality
- Avoidance of any kind of contamination
Our suppliers and logistics partners are carefully selected and work without exception according to Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP).
In this way, we ensure the highest and consistent quality standards along the entire supply chain, from the development, through the production to the logistics of our goods.
Guaranteed quality of products along the entire supply chain.
Consistent production of pharmaceutical products according to defined quality standards.
For doctors, pharmacies, medical facilities and patients.
Interesting facts about medical cannabis.
According to the Administrative Court of Düsseldorf:Driving under the influence of medical cannabis allowed.
The 6th Chamber of the Administrative Court of Düsseldorf found that a patient taking medically prescribed medical cannabis may be suitable for driving motor vehicles. The basis for the decision was a medical-psychological assessment of the patient.
First findings from the accompanying survey on the therapy with cannabis drugs.
The Federal Institute for Medicinal Products and Medical Devices carries out a non-interventional scientific monitoring of the treatments for cannabis as medicinal products approved by the health insurance funds. An interim evaluation has recently been published.
The expopharm trade fair will take place in 2020 from 07. – 10 October in Munich.
As Europe’s largest trade fair for the pharmacy market, expopharm creates an ideal framework for an open exchange of knowledge and information. We are back on site with our own stand and are available to visitors on the subject of medical cannabis.